ofloxacin has been researched along with Peritonitis in 40 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred twenty-three cirrhotics with uncomplicated spontaneous bacterial peritonitis (no septic shock, grade II-IV hepatic encephalopathy, serum creatinine level of > 3 mg/dL, and gastrointestinal hemorrhage or ileus) were randomly given oral ofloxacin (64 patients) or intravenous cefotaxime (59 patients)." | 9.08 | Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. ( Arroyo, V; Bañares, R; Castells, L; Clemente, G; Follo, A; Forné, M; Guarner, C; Jimenez De Anta, MT; Llovet, JM; Marco, F; Navasa, M; Planas, R; Rimola, A; Rodés, J; Vargas, V, 1996) |
| "This prospective randomized study is an evaluation of efficacy of cefazolin and ofloxacin in 23 end-stage renal disease (ESRD) patients treated with continuous ambulatory peritoneal dialysis (CAPD) who experienced 38 episodes of peritonitis (P)." | 9.07 | Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients? ( Bren, AF; Gucek, A; Hergouth, V; Lindic, J; Mlinsek, D, 1994) |
| "Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i." | 9.07 | A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). ( Chan, CY; Cheng, IK; Wong, WT, 1991) |
| " Hypoglycemia because of use of levofloxacin is a rarely reported complication." | 7.74 | Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. ( Abraham, J; Jacob, JJ; Kapoor, R; Singh, M, 2008) |
| "Thirty cirrhotic patients with spontaneous bacterial peritonitis were assigned to receive either intravenous (1 g/12 h) cefotaxime for 7 days (n=17) or intravenous (200 mg/12 h) ofloxacin for 2 days followed by oral (200 mg/12 h) ofloxacin for 5 days (n=13)." | 7.72 | Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis. ( Aslan, SL; Buyraç, Z; Colakoğlu, O; Sözmen, B; Taşkiran, B; Unsal, B, 2004) |
| "Seven patients with end-stage renal disease requiring support by continuous ambulatory peritoneal dialysis received once-daily 400 mg oral ofloxacin for 7 days for the treatment of bacterial peritonitis." | 7.69 | The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis. ( Brown, IM; Brown, NM; MacGown, AP; McMullin, CM; Reeves, DS; Tomson, CR; White, LO, 1997) |
| "Eighteen episodes of peritonitis in 16 CAPD patients were treated with oral ofloxacin 400 mg initially, followed by 300 mg daily for a total of 10 days." | 7.67 | Oral treatment of peritonitis in CAPD patients with ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "Two open studies of oral treatment of peritonitis in CAPD patients with ofloxacin are described." | 7.67 | Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "One hundred twenty-three cirrhotics with uncomplicated spontaneous bacterial peritonitis (no septic shock, grade II-IV hepatic encephalopathy, serum creatinine level of > 3 mg/dL, and gastrointestinal hemorrhage or ileus) were randomly given oral ofloxacin (64 patients) or intravenous cefotaxime (59 patients)." | 5.08 | Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. ( Arroyo, V; Bañares, R; Castells, L; Clemente, G; Follo, A; Forné, M; Guarner, C; Jimenez De Anta, MT; Llovet, JM; Marco, F; Navasa, M; Planas, R; Rimola, A; Rodés, J; Vargas, V, 1996) |
| "This prospective randomized study is an evaluation of efficacy of cefazolin and ofloxacin in 23 end-stage renal disease (ESRD) patients treated with continuous ambulatory peritoneal dialysis (CAPD) who experienced 38 episodes of peritonitis (P)." | 5.07 | Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients? ( Bren, AF; Gucek, A; Hergouth, V; Lindic, J; Mlinsek, D, 1994) |
| "Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i." | 5.07 | A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). ( Chan, CY; Cheng, IK; Wong, WT, 1991) |
| "Among several regimes used in the oral treatment of continuous ambulatory peritoneal dialysis (CAPD)--related peritonitis, ciprofloxacin and ofloxacin showed the higher treatment efficacy, with an overall cure rate of 80% over a treatment duration of 10-16 days." | 4.81 | The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis. ( Oreopoulos, D; Passadakis, P, 2001) |
| " Renal-dose levofloxacin was utilized as part of an antimicrobial regimen to treat post-operative peritonitis." | 3.74 | Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia. ( Gregory, J; Huesmann, G; Jakoby, MG; Vallurupalli, S, 2008) |
| " Hypoglycemia because of use of levofloxacin is a rarely reported complication." | 3.74 | Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. ( Abraham, J; Jacob, JJ; Kapoor, R; Singh, M, 2008) |
| "Thirty cirrhotic patients with spontaneous bacterial peritonitis were assigned to receive either intravenous (1 g/12 h) cefotaxime for 7 days (n=17) or intravenous (200 mg/12 h) ofloxacin for 2 days followed by oral (200 mg/12 h) ofloxacin for 5 days (n=13)." | 3.72 | Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis. ( Aslan, SL; Buyraç, Z; Colakoğlu, O; Sözmen, B; Taşkiran, B; Unsal, B, 2004) |
| "Seven patients with end-stage renal disease requiring support by continuous ambulatory peritoneal dialysis received once-daily 400 mg oral ofloxacin for 7 days for the treatment of bacterial peritonitis." | 3.69 | The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis. ( Brown, IM; Brown, NM; MacGown, AP; McMullin, CM; Reeves, DS; Tomson, CR; White, LO, 1997) |
| "Eighteen episodes of peritonitis in 16 CAPD patients were treated with oral ofloxacin 400 mg initially, followed by 300 mg daily for a total of 10 days." | 3.67 | Oral treatment of peritonitis in CAPD patients with ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "Two open studies of oral treatment of peritonitis in CAPD patients with ofloxacin are described." | 3.67 | Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "Levofloxacin seems to be a good alternative treatment for patients with uncomplicated spontaneous ascites infections." | 1.36 | A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. ( Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T, 2010) |
| "Cryoglobulinemia has been described in infectious diseases, but in only three patients with brucellosis." | 1.33 | Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis. ( Hermida Lazcano, I; Sáez Méndez, L; Solera Santos, J, 2005) |
| "The optimal period of antibiotic treatment of hepatic failure with SBP should be from 7 days to 10 days." | 1.32 | [A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis]. ( Du, N; He, WP; Ji, W; Li, HW; Wang, HF; Xia, J; Zhao, P, 2004) |
| "Ofloxacin was measured using high-pressure liquid chromatography (HPLC) in the serum and peritoneal effluent over 24 hours." | 1.29 | Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis. ( Chan, CY; Chau, PY; Cheng, IK; Kou, M; Kumana, CR; Siu, LK, 1993) |
| " every 6 h for one day only, while 4 patients with acute peritonitis were treated with this same dosage every 4 h for 3 days, then every 6 h for the next 7 days." | 1.28 | Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients. ( Borner, K; Conrad, W; Hain, H; Kampf, D, 1991) |
| "7 hours after administration and the mean elimination half-life of OFX was 25 hours." | 1.27 | Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. ( Chan, MK; Chan, WW; Chau, PY, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.50) | 18.7374 |
| 1990's | 20 (50.00) | 18.2507 |
| 2000's | 14 (35.00) | 29.6817 |
| 2010's | 3 (7.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vallurupalli, S | 1 |
| Huesmann, G | 1 |
| Gregory, J | 1 |
| Jakoby, MG | 1 |
| Yakar, T | 1 |
| Güçlü, M | 1 |
| Serin, E | 1 |
| Alişkan, H | 1 |
| Husamettin, E | 1 |
| Monescillo Francia, A | 1 |
| Mohan, P | 1 |
| Venkataraman, J | 1 |
| Shi, G | 1 |
| Chen, X | 1 |
| Wang, H | 1 |
| Wang, S | 1 |
| Guo, X | 1 |
| Zhang, X | 1 |
| Alberti, LE | 1 |
| Lopez-Gomez, A | 1 |
| Alberti-Flor, JJ | 1 |
| Taşkiran, B | 1 |
| Colakoğlu, O | 1 |
| Sözmen, B | 1 |
| Unsal, B | 1 |
| Aslan, SL | 1 |
| Buyraç, Z | 1 |
| Li, HW | 1 |
| Zhao, P | 1 |
| Wang, HF | 1 |
| Ji, W | 1 |
| He, WP | 1 |
| Du, N | 1 |
| Xia, J | 1 |
| Hermida Lazcano, I | 1 |
| Sáez Méndez, L | 1 |
| Solera Santos, J | 1 |
| Guettrot-Imbert, G | 1 |
| Letranchant, L | 1 |
| Gallot, D | 1 |
| Romaszko, C | 1 |
| Laurichesse, H | 1 |
| Esposito, S | 1 |
| Noviello, S | 1 |
| Leone, S | 1 |
| Ianniello, F | 1 |
| Ascione, T | 1 |
| Gaeta, GB | 1 |
| Shinagawa, N | 1 |
| Yura, J | 1 |
| Takeyama, H | 1 |
| Taniguchi, M | 1 |
| Mikamo, H | 1 |
| Tamaya, T | 1 |
| Ito, K | 1 |
| Izumi, K | 1 |
| Tanaka, K | 1 |
| Watanabe, K | 1 |
| Singh, M | 1 |
| Jacob, JJ | 1 |
| Kapoor, R | 1 |
| Abraham, J | 1 |
| Cormican, MG | 1 |
| Runyon, BA | 1 |
| Jones, RN | 1 |
| Battista, C | 1 |
| Kane, MP | 1 |
| Moon, DG | 1 |
| Bailie, GR | 1 |
| Gucek, A | 1 |
| Bren, AF | 1 |
| Lindic, J | 1 |
| Hergouth, V | 1 |
| Mlinsek, D | 1 |
| Flament-Saillour, M | 1 |
| de Truchis, P | 1 |
| Risbourg, M | 1 |
| Nordmann, P | 1 |
| Barretti, P | 1 |
| Bignardi, JH | 1 |
| Soares, VA | 1 |
| Sesso, R | 1 |
| Parisio, K | 1 |
| Dalboni, A | 1 |
| Rabelo, T | 1 |
| Barbosa, D | 1 |
| Cendoroglo, M | 1 |
| Pignatari, A | 1 |
| Draibe, S | 1 |
| Ajzen, H | 1 |
| Cheng, IK | 3 |
| Chau, PY | 4 |
| Kumana, CR | 1 |
| Chan, CY | 2 |
| Kou, M | 1 |
| Siu, LK | 1 |
| Riley, UB | 1 |
| Bignardi, G | 1 |
| Goldberg, L | 1 |
| Johnson, AP | 1 |
| Holmes, B | 1 |
| Navasa, M | 1 |
| Follo, A | 1 |
| Llovet, JM | 1 |
| Clemente, G | 1 |
| Vargas, V | 1 |
| Rimola, A | 1 |
| Marco, F | 1 |
| Guarner, C | 1 |
| Forné, M | 1 |
| Planas, R | 1 |
| Bañares, R | 1 |
| Castells, L | 1 |
| Jimenez De Anta, MT | 1 |
| Arroyo, V | 1 |
| Rodés, J | 1 |
| García-Tsao, G | 1 |
| McMullin, CM | 1 |
| Brown, NM | 1 |
| Brown, IM | 1 |
| Tomson, CR | 1 |
| White, LO | 1 |
| Reeves, DS | 1 |
| MacGown, AP | 1 |
| Winkeltau, GJ | 1 |
| Töns, C | 1 |
| Bertram, P | 1 |
| Schumpelick, V | 1 |
| Vychytil, A | 2 |
| Lorenz, M | 1 |
| Schneider, B | 1 |
| Hörl, WH | 2 |
| Haag-Weber, M | 1 |
| Konner, P | 1 |
| Watschinger, B | 1 |
| Apfalter, P | 1 |
| Passadakis, P | 1 |
| Oreopoulos, D | 1 |
| Soares-Weiser, K | 1 |
| Paul, M | 1 |
| Brezis, M | 1 |
| Leibovici, L | 1 |
| Dan, M | 1 |
| Gutman, R | 1 |
| Biro, A | 1 |
| Kampf, D | 1 |
| Borner, K | 1 |
| Hain, H | 1 |
| Conrad, W | 1 |
| Wong, WT | 1 |
| Janknegt, R | 1 |
| Pagniez, DC | 1 |
| Vrtovsnik, F | 1 |
| Delvallez, L | 1 |
| Reade, R | 1 |
| Dequiedt, P | 1 |
| Tacquet, A | 1 |
| Chan, MK | 4 |
| Ng, WS | 1 |
| Chan, WW | 3 |
3 reviews available for ofloxacin and Peritonitis
| Article | Year |
|---|---|
The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Oflo | 2001 |
Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Evidence-Based Medicine; Female; Gram-Negative Bac | 2002 |
CAPD peritonitis and fluoroquinolones: a review.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous | 1991 |
7 trials available for ofloxacin and Peritonitis
| Article | Year |
|---|---|
[Effectiveness of switch therapy for peritonitis].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Administr | 2007 |
Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
Topics: Adult; Aged; Cefazolin; Female; Humans; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuou | 1994 |
Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Administration, Topical; Adult; Catheters, Indwelling; Female; Fusidic Acid; H | 1994 |
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; C | 1996 |
New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.
Topics: Abdominal Abscess; Adult; Aged; Bacterial Infections; Catheters, Indwelling; Female; Follow-Up Studi | 1998 |
A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Ofloxacin; | 1991 |
A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteria; Cephalothin; Drug Therapy, Combination | 1990 |
30 other studies available for ofloxacin and Peritonitis
| Article | Year |
|---|---|
Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia.
Topics: Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemia; Kidne | 2008 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime | 2010 |
[Spontaneous bacterial peritonitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Humans; Ofloxacin; Peritonitis; Primary Prevention | 2009 |
Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefotaxime; Drug Therapy, Combina | 2011 |
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Chromatography, High Pressure Liquid; Dise | 2012 |
Spontaneous bacterial peritonitis in a patient with myxedema ascites.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ascites; Female; Humans; Hypothyroidism; Klebsiella | 2003 |
Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.
Topics: Adult; Aged; Analysis of Variance; Cefotaxime; Dose-Response Relationship, Drug; Drug Administration | 2004 |
[A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; | 2004 |
Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Brucella melitensis; Brucellosis; Cryoglobulinemia; Doxycyclin | 2005 |
[Multiorgan failure due to gonococcal peritonitis in an HIV-HCV co-infected female patient].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ascites; Bacteremia; Carcinoma, Hepatocellular | 2004 |
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofl | 2006 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgica | 2006 |
Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Fatal O | 2008 |
In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Ceftizoxime; Enterobacteriaceae; Hu | 1995 |
Stability of ofloxacin in peritoneal dialysis solutions.
Topics: Bacterial Infections; Chromatography, High Pressure Liquid; Dialysis Solutions; Drug Stability; Huma | 1995 |
Yersinia enterocolitica peritonitis in a patient infected with the human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Male; Ofloxacin; Peritonitis; Yersinia enteroc | 1994 |
Successful treatment of peritonitis in IPD with oral fluoroquinolone.
Topics: Administration, Oral; Ciprofloxacin; Humans; Ofloxacin; Peritoneal Dialysis; Peritoneal Dialysis, Co | 1994 |
Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
Topics: Aged; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Ofloxacin; Peritoneal | 1993 |
Quinolone resistance in Oligella urethralis-associated chronic ambulatory peritoneal dialysis peritonitis.
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Huma | 1996 |
Treatment of spontaneous bacterial peritonitis with oral ofloxacin: inpatient or outpatient therapy?
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Humans; Ofloxacin; Peritonitis | 1996 |
The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Aged; Anti-Infective Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ofloxa | 1997 |
[Stage-oriented antibiotic therapy of peritonitis. Prospective study].
Topics: Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; | 1997 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; | 1999 |
A case of continuous ambulatory peritoneal dialysis peritonitis with an uncommon organism and an atypical clinical course.
Topics: C-Reactive Protein; Dialysis Solutions; Equipment Failure; Graft Rejection; Humans; Kidney Transplan | 2001 |
Peritonitis caused by Pseudomonas putrefaciens in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Aged; Female; Gentamicins; Humans; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulator | 1992 |
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients.
Topics: Acute Disease; Aged; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; | 1991 |
Ofloxacin treatment may mask tuberculous peritonitis in CAPD patients.
Topics: Aged; Aged, 80 and over; Humans; Male; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Perito | 1991 |
Oral treatment of peritonitis in CAPD patients with ofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Administration Schedule; Female; Humans; Male; M | 1988 |
Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Humans; Ofloxacin; Perito | 1988 |
Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
Topics: Adult; Anti-Infective Agents; Ascitic Fluid; Creatinine; Female; Humans; Male; Middle Aged; Ofloxaci | 1987 |